Bristol Myers backs a European VC's record-setting biotech venture fund, which tops out at $600M
A European biotech venture group with a yen for transatlantic deals will face whatever is coming on the investment side of the business with a new fund that claims boasting rights as the largest life sciences fund ever raised on the continent.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
